11.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FGEN Giù?
Forum
Previsione
Fibrogen Inc Borsa (FGEN) Ultime notizie
Using data filters to optimize entry into FibroGen Inc.2025 Market Overview & Technical Pattern Based Signals - Newser
Is FibroGen Inc. stock poised for growthPortfolio Gains Summary & Community Consensus Picks - Newser
Will breakout in FibroGen Inc. lead to full recovery2025 Short Interest & Daily Profit Focused Screening - Newser
Volume spikes in FibroGen Inc. stock – what they mean2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
FibroGen stock maintains Buy rating at H.C. Wainwright after China sale - Investing.com
How hedge fund analytics apply to FibroGen Inc. stockJobs Report & Community Verified Watchlist Alerts - Newser
Regression analysis insights on FibroGen Inc. performanceQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser
Using R and stats models for FibroGen Inc. forecastingWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
How sentiment analysis helps forecast FibroGen Inc.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - Newser
Using fundamentals and technicals on FibroGen Inc.2025 Historical Comparison & Verified Short-Term Plans - Newser
FibroGen Inc. stock outlook for YEARJuly 2025 Levels & Weekly High Conviction Ideas - Newser
Is FibroGen Inc. stock forming a triangle patternJuly 2025 Setups & Verified Trade Idea Suggestions - khodrobank.com
What technical models suggest about FibroGen Inc.’s comebackEntry Point & Smart Investment Allocation Insights - Newser
What are analysts’ price targets for FibroGen Inc.July 2025 Update & Long-Term Safe Investment Ideas - khodrobank.com
Custom strategy builders for tracking FibroGen Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - Newser
How to use a screener to detect FibroGen Inc. breakoutsWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
FibroGen Sells Subsidiary to AstraZeneca for $220M - MSN
Smart tools for monitoring FibroGen Inc.’s price actionJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
FibroGen Completes Sale of Chinese Subsidiary to AstraZeneca - MarketScreener
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million - GlobeNewswire
$220M Deal: FibroGen Divests China Operations to AstraZeneca, Extends Cash Runway to 2028 - Stock Titan
Applying big data sentiment scoring on FibroGen Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - Newser
Is FibroGen Inc. stock a value trapJuly 2025 Earnings & Low Drawdown Trading Techniques - khodrobank.com
Breakouts Watch: Can FibroGen Inc. deliver consistent dividends2025 Macro Impact & Weekly Market Pulse Updates - khodrobank.com
Is a relief rally coming for FibroGen Inc. holdersTrade Exit Summary & Proven Capital Preservation Tips - Newser
Can FibroGen Inc. reach all time highs this yearJuly 2025 Action & Growth Oriented Trade Recommendations - khodrobank.com
FibroGen Inc. stock daily chart insightsMarket Movers & AI Powered Trade Plan Recommendations - Newser
What indicators show strength in FibroGen Inc.Earnings Overview Report & Long-Term Growth Portfolio Plans - Newser
Is FibroGen Inc. a good ESG investment2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - khodrobank.com
Traders Watching For Reversal Pattern in FibroGen Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Price momentum metrics for FibroGen Inc. explainedWeekly Profit Summary & Low Risk High Win Rate Picks - Newser
Is FibroGen Inc. stock entering bullish territoryRate Hike & AI Enhanced Trading Alerts - Newser
Analyzing FibroGen Inc. with multi timeframe chartsBull Run & Real-Time Volume Spike Alerts - Newser
Order Flow Trends Show Accumulation in FibroGen Inc. getLinesFromResByArray error: size == 0 - 클래시안
Using RSI to spot recovery in FibroGen Inc.Bond Market & Long-Term Safe Investment Plans - Newser
FibroGen Inc. stock trendline breakdownPortfolio Risk Report & Free Technical Pattern Based Buy Signals - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):